Skip to main content

URMC Logo

URMC / Research / Research@URMC
Pathology Expert Shares Personalized Medicine Tool

Pathology Expert Shares Personalized Medicine Tool

UR Pathology Professor David G. Hicks, M.D., a national leader in using molecular technology to diagnose breast cancer, helped to design a new tool to assist other U.S. pathologists in how to personalize treatment for patients with invasive disease.

7/31/2014
Wilmot Cancer Institute Scientists Receive $2M from NCI

Wilmot Cancer Institute Scientists Receive $2M from NCI

The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue their study of a gene network that controls cancer progression, with a focus on pancreatic cancer.

6/25/2014
Nature Gives Shout-Out to Wilmot for Immune Therapy Research

Nature Gives Shout-Out to Wilmot for Immune Therapy Research

One of the big topics in cancer research is immunotherapy and the need for a new generation of drugs that spur the immune system to fight tumors. John Frelinger’s lab was featured in a news article in the journal Nature, for its work on refining interleukin-2.

6/4/2014
Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Using Cancer’s Fingerprint, UR Researchers Clinch a Diagnosis

Rochester scientists are using a gene test to diagnose a difficult-to-detect form of bone marrow cancer – an example of how academic medical centers are applying new technology in ways that play to their strengths to achieve better patient care.

3/5/2014
Prostate Cancer Danger Zone: More Likely for Older, Black Men

Prostate Cancer Danger Zone: More Likely for Older, Black Men

When prostate cancer is detected through a screening test and no symptoms are present, logic would say the disease is probably insignificant and the patient can avoid aggressive treatment. Yet statistics tell a different story: 1 in 6 of these men will have higher-risk disease, according to a University of Rochester study published in Frontiers in Oncology.

1/28/2014